Gruppo RA - Search Results

1

Antithrombin-III for the treatment of chemotherapy-induced organ dysfunction following bone marrow transplantation.

Morris JD, Harris RE, Hashmi R, Sambrano JE, Gruppo RA, Becker AT, Morris CL. Morris JD, et al. Among authors: gruppo ra. Bone Marrow Transplant. 1997 Nov;20(10):871-8. doi: 10.1038/sj.bmt.1700985. Bone Marrow Transplant. 1997. PMID: 9404929

2

Influence of plasma and red cell factors on the rheologic properties of oxygenated sickle blood during clinical steady state.

Morris CL, Gruppo RA, Shukla R, Rucknagel DL. Morris CL, et al. Among authors: gruppo ra. J Lab Clin Med. 1991 Oct;118(4):332-42. J Lab Clin Med. 1991. PMID: 1940575

3

Evaluation of the yield stress of normal blood as a function of fibrinogen concentration and hematocrit.

Morris CL, Rucknagel DL, Shukla R, Gruppo RA, Smith CM 2nd, Blackshear P Jr. Morris CL, et al. Among authors: gruppo ra. Microvasc Res. 1989 May;37(3):323-38. doi: 10.1016/0026-2862(89)90050-2. Microvasc Res. 1989. PMID: 2733604

4

The pathophysiology of alveolar osteonecrosis of the jaw: anticardiolipin antibodies, thrombophilia, and hypofibrinolysis.

Gruppo R, Glueck CJ, McMahon RE, Bouquot J, Rabinovich BA, Becker A, Tracy T, Wang P. Gruppo R, et al. J Lab Clin Med. 1996 May;127(5):481-8. doi: 10.1016/s0022-2143(96)90065-7. J Lab Clin Med. 1996. PMID: 8621985

5

The relationship of mutations in the MTHFR, prothrombin, and PAI-1 genes to plasma levels of homocysteine, prothrombin, and PAI-1 in children and adults.

Balasa VV, Gruppo RA, Glueck CJ, Stroop D, Becker A, Pillow A, Wang P. Balasa VV, et al. Among authors: gruppo ra. Thromb Haemost. 1999 May;81(5):739-44. Thromb Haemost. 1999. PMID: 10365747

6

Favorable histology, MYCN-amplified 4S neonatal neuroblastoma.

Chan EL, Harris RE, Emery KH, Gelfand MJ, Collins MH, Gruppo RA. Chan EL, et al. Among authors: gruppo ra. Pediatr Blood Cancer. 2007 Apr;48(4):479-82. doi: 10.1002/pbc.20705. Pediatr Blood Cancer. 2007. PMID: 16333837 Review.

7

Sensitivity, specificity and predictive value of modified assays for activated protein C resistance in children.

Brandt G, Gruppo R, Glueck CJ, Stroop D, Becker A, Pillow A, Wang P. Brandt G, et al. Thromb Haemost. 1998 Mar;79(3):567-70. Thromb Haemost. 1998. PMID: 9531042

8

Pediatric hematologic and oncologic emergencies.

Lampkin BC, Gruppo RA, Lobel JS, Harris RE, Wong KY, Neely JE. Lampkin BC, et al. Among authors: gruppo ra. Emerg Med Clin North Am. 1983 Apr;1(1):63-86. Emerg Med Clin North Am. 1983. PMID: 6394287 Review.

9

Resistance to activated protein C and Legg-Perthes disease.

Glueck CJ, Brandt G, Gruppo R, Crawford A, Roy D, Tracy T, Stroop D, Wang P, Becker A. Glueck CJ, et al. Clin Orthop Relat Res. 1997 May;(338):139-52. doi: 10.1097/00003086-199705000-00021. Clin Orthop Relat Res. 1997. PMID: 9170375

10

A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.

Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G 3rd, Lee M. Bray GL, et al. Blood. 1994 May 1;83(9):2428-35. Blood. 1994. PMID: 8167332 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters